UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

The genetic and molecular pathogenesis of myelodysplastic syndromes

European journal of haematology, 2018-09, Vol.101 (3), p.260-271

2018

Volltextzugriff (PDF)

Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map

Blood reviews, 2020-07, Vol.42, p.100706-100706, Article 100706

2020

Volltextzugriff (PDF)

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved

Blood reviews, 2021-05, Vol.47, p.100773-100773, Article 100773

2021

Volltextzugriff (PDF)

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Leukemia, 2020-12, Vol.34 (12), p.3149-3160

2020

Volltextzugriff (PDF)

Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress

Expert review of anticancer therapy, 2023-09, Vol.ahead-of-print (ahead-of-print), p.1-9

2023

Volltextzugriff (PDF)

Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy

Annals of hematology, 2022-05, Vol.101 (5), p.1145-1147

2022

Volltextzugriff (PDF)

Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges

Blood reviews, 2019-07, Vol.36, p.70-87

2019

Volltextzugriff (PDF)

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis

Haematologica (Roma), 2023-08, Vol.108 (8), p.2218

2023

Volltextzugriff (PDF)

Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia

Leukemia & lymphoma, 2023-01, Vol.64 (2), p.454-461

2023

Volltextzugriff (PDF)

Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.1998-2004

2021

Volltextzugriff (PDF)

Are We Moving the Needle for Patients with TP53 -Mutated Acute Myeloid Leukemia?

Cancers, 2022-05, Vol.14 (10), p.2434

2022

Volltextzugriff (PDF)

Emerging agents and regimens for polycythemia vera and essential thrombocythemia

Biomarker research, 2021-05, Vol.9 (1), p.1-40, Article 40

2021

Volltextzugriff (PDF)

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it

Blood reviews, 2019-03, Vol.34, p.1-15

2019

Volltextzugriff (PDF)

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood cancer journal (New York), 2024-02, Vol.14 (1), p.32-32, Article 32

2024

Volltextzugriff (PDF)

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.18889-18900

2023

Volltextzugriff (PDF)

Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts

European journal of haematology, 2018-12, Vol.101 (6), p.711-720

2018

Volltextzugriff (PDF)

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States

Therapeutic advances in hematology, 2021, Vol.12, p.20406207211043404-20406207211043404

2021

Volltextzugriff (PDF)

Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways

Blood reviews, 2021-01, Vol.45, p.100709-100709, Article 100709

2021

Volltextzugriff (PDF)

The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia

Hemato, 2021-12, Vol.2 (4), p.748-763

2021

Volltextzugriff (PDF)

Management of the Older Patient with Myelodysplastic Syndrome

Drugs & aging, 2021-09, Vol.38 (9), p.751-767

2021

Volltextzugriff (PDF)

Challenges in management of older patients with chronic myeloid leukemia

Leukemia & lymphoma, 2024-04, p.1-14

2024

Volltextzugriff (PDF)

Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1534-1543

2022

Volltextzugriff (PDF)

The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responses

Blood reviews, 2021-07, Vol.48, p.100806-100806, Article 100806

2021

Volltextzugriff (PDF)

What is the best pharmacotherapeutic strategy for treating chronic myeloid leukemia in the elderly?

Expert opinion on pharmacotherapy, 2019-07, Vol.20 (10), p.1169-1173

2019

Volltextzugriff (PDF)

A clandestine culprit with critical consequences: Benzene and acute myeloid leukemia

Blood reviews, 2021-05, Vol.47, p.100736, Article 100736

2021

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(138)
Berichte
(2)

Sprache

Englisch
(140)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Hematology
(75)
Humans
(55)
Oncology
(41)
Acute Myeloid Leukemia
(29)
Aml
(21)
Leukemia
(19)
Leukemia, Myeloid, Acute - Drug Therapy
(17)
Patients
(14)
Aged
(13)
Mutation
(13)
Leukemia, Myeloid, Acute - Genetics
(12)
Retrospective Studies
(12)
Leukemia, Myeloid, Acute - Diagnosis
(10)
Mds
(10)
Myelodysplastic Syndrome
(10)
Prognosis
(10)
Chemotherapy
(9)
Leukemia, Myeloid, Acute - Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(35)
Blood Advances
(11)
Leukemia & Lymphoma
(11)
Blood Reviews
(10)
American Journal Of Hematology
(6)
Clinical Lymphoma, Myeloma And Leukemia
(6)
Annals Of Hematology
(5)
Cancer
(5)
Expert Review Of Hematology
(5)
Leukemia
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The genetic and molecular pathogenesis of myelodysplastic syndromes

Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress

Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy

Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis

Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia

Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data

Are We Moving the Needle for Patients with TP53 -Mutated Acute Myeloid Leukemia?

Emerging agents and regimens for polycythemia vera and essential thrombocythemia

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia

Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States

Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways

The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia

Management of the Older Patient with Myelodysplastic Syndrome

Challenges in management of older patients with chronic myeloid leukemia

Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis

The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responses

What is the best pharmacotherapeutic strategy for treating chronic myeloid leukemia in the elderly?

A clandestine culprit with critical consequences: Benzene and acute myeloid leukemia

Suchergebnisse filtern